Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Covington
Fuji
Novartis
Mallinckrodt
Daiichi Sankyo
Medtronic
Express Scripts
Harvard Business School
Citi

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,540,282

« Back to Dashboard

Summary for Patent: 7,540,282
Title:Reservoir pressure system for medicament inhaler
Abstract: An inhaler includes an accurate and consistent mechanical dose metering system that dispenses dry powdered medicament in discrete amounts or doses for patient inhalation, a pressure relief system that manages pressure within a medicament reservoir of the inhaler to ensure consistently dispensed doses, and a dose counting system indicating the number of doses remaining in the inhaler.
Inventor(s): O'Leary; David (Essex, GB)
Assignee: Norton Healthcare Ltd (GB)
Application Number:09/888,199
Patent Claim Types:
see list of patent claims
Delivery; Use;

Drugs Protected by US Patent 7,540,282

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Teva Branded Pharm PROAIR RESPICLICK albuterol sulfate POWDER, METERED;INHALATION 205636-001 Mar 31, 2015 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Teva Pharm AIRDUO RESPICLICK fluticasone propionate; salmeterol xinafoate POWDER;INHALATION 208799-001 Jan 27, 2017 RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Teva Pharm AIRDUO RESPICLICK fluticasone propionate; salmeterol xinafoate POWDER;INHALATION 208799-002 Jan 27, 2017 RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Teva Pharm AIRDUO RESPICLICK fluticasone propionate; salmeterol xinafoate POWDER;INHALATION 208799-003 Jan 27, 2017 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Teva Pharm ARMONAIR RESPICLICK fluticasone propionate POWDER;INHALATION 208798-001 Jan 27, 2017 RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Teva Pharm ARMONAIR RESPICLICK fluticasone propionate POWDER;INHALATION 208798-002 Jan 27, 2017 RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Teva Pharm ARMONAIR RESPICLICK fluticasone propionate POWDER;INHALATION 208798-003 Jan 27, 2017 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 7,540,282

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,871,646 De-agglomerator for breath-actuated dry powder inhaler ➤ Subscribe
6,655,381 Pre-metered dose magazine for breath-actuated dry powder inhaler ➤ Subscribe
6,701,917 Dose counter for medicament inhaler ➤ Subscribe
8,006,690 Reservoir pressure system for medicament inhaler ➤ Subscribe
6,748,947 De-agglomerator for breath-actuated dry powder inhaler ➤ Subscribe
6,718,972 Dose metering system for medicament inhaler ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,540,282

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 2552468 ➤ Subscribe
Canada 2586482 ➤ Subscribe
Cyprus 1110161 ➤ Subscribe
Cyprus 1115748 ➤ Subscribe
Cyprus 1117140 ➤ Subscribe
Germany 60107107 ➤ Subscribe
Germany 60136808 ➤ Subscribe
Germany 60141579 ➤ Subscribe
Denmark 1294421 ➤ Subscribe
Denmark 1330280 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Fuji
US Army
Teva
Federal Trade Commission
Express Scripts
Daiichi Sankyo
Accenture
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot